Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) serves as a notification to the U.S. Securities and Exchange Commission regarding the submission of its Annual Report on Form 20-F. The report covers the fiscal year ended 31 December 2015 and was filed with the SEC on 18 March 2016. The filing was made in accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual.
Key Financial Metrics
The provided text is a procedural notification and does not contain specific financial data. It does not report revenue, profit, cash flow, margins, debt, or liquidity figures. Investors are directed to the full Annual Report on Form 20-F for audited financial statements.
Material Changes
The filing text does not provide data to compare current period performance against prior periods. No material changes in financial metrics are detailed in this specific document.
Guidance, Outlook, and Risks
- Forward-Looking Statements: GSK includes a cautionary statement noting that any forward-looking statements or projections are subject to risks and uncertainties that may cause actual results to differ materially.
- Risk Factors: Specific risks are referenced as being described under Item 3.D "Risk factors" in the company's Annual Report on Form 20-F for 2015, but are not listed in this text.
- Shareholder Information: Shareholders may receive notifications via email by registering on www.shareview.co.uk. Hard copies of the report and the Notice of Annual General Meeting were expected to be available on or about 30 March 2016.
Investor Verification Checklist
- Verify the availability of the full 2015 Annual Report on Form 20-F on the SEC website (www.sec.gov) or GSK's corporate reporting site (www.gsk.com/corporatereporting) to obtain actual financial figures.
- Review Item 3.D "Risk factors" within the Form 20-F for detailed disclosures on uncertainties affecting future projections.
- Confirm the date of the Annual General Meeting via the Notice of Annual General Meeting, expected to be distributed around 30 March 2016.
- Check for any subsequent updates or amendments to the 2015 financial statements filed after the 18 March 2016 date.